Cryptosporidium infection is now a well-reorganized cause of diarrhea in immunologically healthy and immunocompromised humans throughout the world, largely due to the recognition of a severe form of the infection in patients with AIDS. Diarrheal illness due to Cryptosporidium infection of the gastrointestinal tract in persons with AIDS becomes progressively worse with time and may be a major factor leading to death. At the present time, there is no effective therapy for treating or preventing cryptosporidiosis. Attempts to design treatments for cryptosporidiosis have been largely based on using methods of intervention previously exploited in other disease causing organisms. This approach has not been successful and is limited because it is based on knowledge discovered independently of Cryptosporidium biology. The lack of a basic understanding of parasite biology has been a limiting factor is designing effective means of treating and preventing disease. In our research proposal, we have elected to take a comprehensive, basic biological approach to studying the biology of C. parvum, in order to provide the foundation for rationale design of new therapies for cryptosporidiosis. The goal of our studies is to identify and characterize those genes and gene products, both of the parasite and of the parasite and the host cells, whose mRNAs are specifically expressed in C. parvum-infected cells. The PCR-based technique of differential mRNA display will be used to clone host genes that are down regulated during infection with C. parvum.
In specific aim 2, we will generate monoclonal antibodies specific for C. parvum-infected cells to detect changes in gene expression that are not the result of modulating mRNA levels. These will include those parasite proteins that are synthesized in sporozoites and become expressed in the host cell after penetration and subsequent development. The monoclonal antibodies will be used to clone the cDNAs that experiments to characterize the differentially expressed genes to begin to assign putative functions. These will include determination of nucleic acid sequences and gene origin, host vs. parasite, kinetics of expression, and in localization of the mRNA and protein products. We will focus on characterizing those genes that represent unique aspects of Cryptosporidium biology and host-parasite interaction. Once we have generated the necessary DNA and antibody reagents, we will perform key experiments in vivo, such as in situ localization of mRNA and protein expression, to confirm the conclusions of the in vitro model. These studies will lay the foundation to start to understand specific aspects of the biology of C. parvum and host- parasite interactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29AI035479-01
Application #
2071168
Study Section
AIDS and Related Research Study Section 5 (ARRE)
Project Start
1994-01-01
Project End
1994-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Montana State University Bozeman
Department
Veterinary Sciences
Type
Schools of Earth Sciences/Natur
DUNS #
City
Bozeman
State
MT
Country
United States
Zip Code
59717
Liu, Chang; Wang, Liangjie; Lancto, Cheryl A et al. (2009) Characterization of a Cryptosporidium parvum protein that binds single-stranded G-strand telomeric DNA. Mol Biochem Parasitol 165:132-41
Deng, Mingqi; Lancto, Cheryl A; Abrahamsen, Mitchell S (2004) Cryptosporidium parvum regulation of human epithelial cell gene expression. Int J Parasitol 34:73-82
Deng, Mingqi; Templeton, Thomas J; London, Nicole R et al. (2002) Cryptosporidium parvum genes containing thrombospondin type 1 domains. Infect Immun 70:6987-95
Liu, C; Abrahamsen, M S (1999) Identification of a putative telomeric repeat DNA binding factor of Cryptosporidium parvum. J Eukaryot Microbiol 46:50S-51S
Liu, C; Vigdorovich, V; Kapur, V et al. (1999) A random survey of the Cryptosporidium parvum genome. Infect Immun 67:3960-9
Schroeder, A A; Lawrence, C E; Abrahamsen, M S (1999) Differential mRNA display cloning and characterization of a Cryptosporidium parvum gene expressed during intracellular development. J Parasitol 85:213-20
Abrahamsen, M S; Schroeder, A A (1999) Characterization of intracellular Cryptosporidium parvum gene expression. Mol Biochem Parasitol 104:141-6
Schroeder, A A; Brown, A M; Abrahamsen, M S (1998) Identification and cloning of a developmentally regulated Cryptosporidium parvum gene by differential mRNA display PCR. Gene 216:327-34
Abrahamsen, M S; Lancto, C A; Walcheck, B et al. (1997) Localization of alpha/beta and gamma/delta T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves. Infect Immun 65:2428-33
Abrahamsen, M S; Schroeder, A A; Lancto, C A (1996) Differential mRNA display analysis of gene expression in Cryptosporidium parvum-infected HCT-8 cells. J Eukaryot Microbiol 43:80S-81S

Showing the most recent 10 out of 11 publications